Biomarker Testing

/Biomarker Testing
Biomarker Testing 2017-07-04T10:23:08+00:00

Biomarkers have emerged as an important tool in drug development process during both the preclinical and clinical phases of candidate compound evaluation. Given the number and overall complexity of available biomarkers on the market, the determination of which biomarkers to evaluate can at times be challenging. In conjunction with board-certified pathologists and toxicologists, MPI Research has committed to developing panels of assays designed to meet your specific study needs, while fulfilling regulatory requirements. Our highly knowledgeable team has experience in the development of the following biomarkers

Acute Phase Proteins

  • CRP
  • α-2-macroglobulin
  • α-1-acid glycoprotein
  • Haptoglobin
  • TIMP-1

Immunoglobulins

  • Total IgG
  • Total IgM
  • Total IgA
  • Total IgE
  • Anti-KLH IgG
  • Anti-KLH IgM
  • Anti-Tetanus IgG
  • Anti-Tetanus IgM

Cytokines

  • IL-1β
  • IL-1α
  • IL-1RA
  • IL-2
  • IL-4
  • IL-5
  • IL-6
  • IL-8
  • IL-10
  • IL-13
  • IL-12p40
  • IL-12p70
  • IL-17a
  • IL-18
  • IFN-γ
  • MCP-1 (CCL2)
  • IP-10 (CXCL10)
  • KC/GRO
  • TNF-α
  • VEGF
  • sCD40
  • Bb Fragment
  • C3a
  • CH50
  • SC5b-9
  • Total Complement Complex (TCC)

Complement

  • Complement Total C3
  • In Vitro Cytokine Release Assays
  • Insulin
  • Insulin Growth Factor 1 (IGF-1)
  • Bone ALP
  • Bone TRAP
  • CTX-1
  • Osteocalcin
  • Aldosterone
  • Cortisol
  • Intact PTH
  • Total T4
  • Free T4
  • Total T3
  • Free T3
  • Prolactin
  • Testosterone
  • Progesterone
  • Estradiol
  • Growth Hormone
  • ACTH
  • FSH
  • TSH
  • Ferritin
  • Transferrin
  • Erythropoietin (EPO)
  • Troponin I
  • CK-MB
  • Myoglobin
  • KIM-1
  • Osteopontin
  • Albumin
  • NGAL
  • Beta-2-Microglobulin
  • Cystatin C
  • Clusterin
  • E-selectin
  • Angiopoietin 2
  • VEGF

To inquire about additional biomarkers not listed or speak to one of our experts, please contact us today at info@mpiresearch.com.